Wilms' tumor in children: An overview

Nephron - Clinical Practice

Volumn 108, Issue 2, 2008, Pages

  Varan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Wilms' tumor; Wilms' tumor, children; Wilms' tumor, treatment

Indexed keywords

DACTINOMYCIN; ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CANCER STAGING; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; KIDNEY SURGERY; MEDICAL SOCIETY; NEPHROBLASTOMA; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL; UNITED STATES; CHILD; CLINICAL TRIAL; GENETICS; KIDNEY TUMOR; MULTIMODALITY CANCER THERAPY; MUTATION; PROGNOSIS; REVIEW;

ANTINEOPLASTIC AGENTS; CHILD; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; KIDNEY NEOPLASMS; MUTATION; NEOPLASM STAGING; PROGNOSIS; WILMS TUMOR;

EID: 39549123055     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113012     Document Type: Short Survey

References (71)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics 2006. CA Cancer J Clin 2006;56:106-130.
2. Rance TF: Case of fungus haematodes of the kidnies. Med Phys J 1814;32:19-25.
3. Wilms M: Die Mischgeschwülste der Niere. Leipzig, A Georgi, 1899, pp 1-90.
4. Bernstein L, Linet M, Smith MA, Olshan AF: Renal tumors; in Ries LAG, Smith MA, Gurney JG (eds): Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. National Cancer Institute, SEER Program, Bethesda, NIH Publ No 99-4649, 1999, pp 79-90.
5. Gurney JG, Bondy ML: Epidemiology of childhood cancer; in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology, ed 5. Philadelphia, Lippincott Williams & Wilkins, 2006, pp 1-13.
6. Kramer S, Meadows AT, Jarrett P: Racial variation in incidence of Wilms' tumor: relationship to congenital anomalies. Med Pediatr Oncol 1984;12:401-405.
7. Breslow NE, Langholz B: Childhood cancer incidence: geographical and temporal variations. Int J Cancer 1983;32:703-716.
8. Kutluk T: First national pediatric cancer registry in Turkey: a Turkish Pediatric Oncology Group (TPOG) study. Pediatr Blood Cancer 2004;43:452.
9. Dama E, Pastore G, Luisa Mosso M, Maria Maule M, Zuccolo L, Magnani C, Merletti F: Time trends and prognostic factors for survival from childhood cancer: a report from the childhood cancer registry of Piedmont (Italy). Eur J Pediatr 2006;165:240-249.
10. Terenziani M, Spreafico F, Collini P, Piva L, Perotti D, Podda M, Gandola L, Massimino M, Cereda S, Cefalo G, Luksch R, Casanova M, Ferrari A, Polastri D, Valagussa P, Fossati-Bellani F: Adult Wilms' tumor: a monoinstitutional experience and review of the literature. Cancer 2004;101:289-293.
11. Lee SB, Haber DA: Wilms' tumor and the WT1 gene. Exp Cell Res 2001;264:74-99.
12. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M: WAGR syndrome: a clinical review of 54 cases. Pediatrics 2005;116:984-988.
13. Büyükpamukçu M, Kutluk T, Büyükpamukçu N, Sarialioǧlu F, Akyüz C: Renal tumors with pseudohermaphroditism and glomerular disease. Acta Oncol 1992;31:745-748.
14. Niemitz EL, Feinberg AP, Brandenburg SA, Grundy PE, DeBaun MR: Children with idiopathic hemihypertrophy and Beckwith-Wiedemann syndrome have different constitutional epigenotypes associated with Wilms' tumor. Am J Hum Genet 2005;77:887-891.
15. Dome JS, Coppes MJ: Recent advances in Wilms' tumor genetics. Curr Opin Pediatr 2002;14:5-11.
16. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995;9:650-662.
17. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J: Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 1994;7:91-97.
18. Maiti S, Alam R, Amos CI, Huff V: Frequent association of β-catenin and WT1 mutations in Wilms' tumors: Cancer Res 2000;60:6288-6292.
19. Ruteshouser EC, Huff V: Familial Wilms' tumor. Am J Med Genet 2004;129C:29-34.
20. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PRM, Macklis R, Tomlinson G, Huff V, Green DM: Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 2005;23:7312-7321.
21. Anderson CE, Punnett HH, Huff V, de Chadarévian JP: Characterization of a Wilms' tumor in a 9-year-old girl with trisomy 18. Am J Med Genet 2003;121A:52-55.
22. Pendergrass TW: Congenital anomalies in children with Wilms' tumor. Cancer 1976;37:403-408.
23. Porteus MH, Narkool P, Neuberg D, Guthrie K, Breslow N, Green DM, Diller L: Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 2000;18:2026-2031.
24. Greenberg F, Stein F, Gresik MV, Finegold MJ, Carpenter RJ, Riccardi VM, Beaudet AL: The Perlman familial nephroblastomatosis syndrome. Am J Med Genet 1986;24:101-110.
25. Beckwith JB: Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1983;14:481-492.
26. Beckwith JB, Kiviat NB, Bonadio JF: Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 1990;10:1-36.
27. Beckwith JB, Palmer NF: Histopathology and prognosis of Wilms' tumor: results from the first National Wilms' Tumor Study. Cancer 1978;41:1937-1948.
28. Beckwith JB: National Wilms' Tumor Study: an update for pathologists. Pediatr Dev Pathol 1998;41:79-84.
29. Faria P, Beckwith JB, Mishra K, Zuppan C, Weeks DA, Breslow N, Daniel G: Focal versus diffuse anaplasia in Wilms' tumor - New definitions with prognostic significance: a report from the National Wilms' Tumor Study Group. Am J Surg Pathol 1996;20:909-920.
30. Vujanić GM, Sandstedt B, Harms D, Kelsey A, Leuschner I, de Kraker J, on behalf of the SIOP Nephroblastoma Scientific Committee: Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 2002;38:79-82.
31. Perlman EJ: Pediatric renal tumors: practical updates for the pathologist. Pediatr Dev Pathol 2005;8:320-338.
32. Green DM: Diagnosis and Management of Malignant Solid Tumors in Infants and Children. Boston, Nijhoff, 1985, pp 1-552.
33. Coppes MJ: Serum biological markers and paraneoplastic syndromes in Wilms' tumor. Med Pediatr Oncol 1993;21:213-221.
34. Damgaard-Pedersen K: CT and IVU in the diagnosis of Wilms' tumor. Pediatr Radiol 1980;9:207-211.
35. Donaldson JS, Shkolnik A: Pediatric renal masses. Semin Roentgenol 1988;23:194-204.
36. Cohen MD: Genitourinary tumors (imaging of the primary tumor); in Cohen MD (ed): Imaging of Children with Cancer, ed 1. St Louis, Mosby-Year Book, 1992, pp 60-74.
37. Cohen MD: Staging of Wilms' tumor. Clin Radiol 1993;47:77-81.
38. D'Angio GJ, Rosenberg H, Sharples K, Kelalis P, Breslow N, Green DM: Position paper: Imaging methods for primary renal tumors of childhood: costs versus benefits. Med Pediatr Oncol 1993;21:205-212.
39. Meisel JA, Guthrie KA, Breslow NE, Donaldson SS, Green DM: Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys 1999;44:579-585.
40. Varan A, Büyükpamukçu N, Çaǧlar M, Köksal Y, Yalçin B, Akyüz C, Kutluk T, Büyü kpamukçu M: Prognostic significance of metastatic site at diagnosis in Wilms' tumor: results from a single center. J Pediatr Hematol Oncol 2005;27:188-191.
41. Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P, Coppes MJ: Management of Wilms' tumor: current practice and future goals. Lancet Oncol 2004;5:37-46.
42. Kim S, Chung DH: Pediatric solid malignancies: neuroblastoma and Wilms' tumor. Surg Clin North Am 2006;86:469-487.
43. National Wilms' Tumor Study Committee: Wilms' tumor: status report, 1990. J Clin Oncol 1991;9:877-887.
44. Vujanić GM, Kelsey A, Mitchell C, Shannon RS, Gornall P: The role of biopsy in the diagnosis of renal tumors of childhood: results of the UKCCSG Wilms' tumor study 3. Med Pediatr Oncol 2003;40:18-22.
45. Cozzi DA, Schiavetti A, Morini F, Castello MA, Cozzi F: Nephron-sparing surgery for unilateral primary renal tumor in children. J Pediatr Surg 2001;36:362-365.
46. Wu HY, Snyder HM, D'Angio GJ: Wilms' tumor management. Curr Opin Urol 2005;15:273-276.
47. Green DM, Thomas PRM, Shochat S: The treatment of Wilms' tumor: results of the National Wilms' Tumor Studies. Hematol Oncol Clin North Am 1995;9:1267-1274.
48. Green DM: The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol 2004;22:1366-1372.
49. Metzger ML, Dome JS: Current therapy for Wilms' tumor. Oncologist 2005;10:815-826.
50. D'Angio GJ, Evans AE, Breslow N, Beckwith B, Bishop H, Feigl P, Goodwin W, Leape LL, Sinks LF, Sutow W, Tefft M, Wolff J: The treatment of Wilms' tumor: results of the National Wilms' Tumor Study. Cancer 1976;38:633-646.
51. D'Angio GJ, Breslow N, Beckwith JB, Evans A, Baum E, deLorimier A, Fernbach D, Hrabovsky E, Jones B, Kelalis P, Othersen B, Tefft M, Thomas RM: Treatment of Wilms' tumor: results of the Third National Wilms' Tumor Study. Cancer 1989;64:349-360.
52. Green DM, Breslow NE, Beckwith J, Finklestein JZ, Grundy PE, Thomas PRM, Kim T, Shochat SJ, Haase GM, Ritchey ML, Kelalis PP, D'Angio GJ: Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1998;16:237-245.
53. Breslow NE, Ou SS, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas PRM, D'Angio GJ, Green DM: Doxorubicin for favorable histology, stage II-III Wilms' tumor: results from the National Wilms' Tumor Studies. Cancer 2004;101:1072-1080.
54. De Kraker J, Weitzman S, Voute PA: Preoperative strategies in the management of Wilms' tumor. Hematol Oncol Clin North Am 1995;9:1275-1285.
55. Suryanarayan K, Marina N: Wilms' tumor: optimal treatment strategies. Drugs 1998;56:597-605.
56. Tournade MF, Com-Nougué C, de Kraker J, Ludwig R, Rey A, Burgers JMB, Sandstedt B, Godzinski J, Carli M, Potter R, Zucker JM, for the International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee: Optimal duration of preoperative therapy in unilateral and non-metastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 2001;19:488-500.
57. De Kraker J, van Tinteren H, Pein F, Sandstedt B, Godzinski J, Tournade MF, for the International Society of Pediatric Oncology Nephroblastoma Trial Committee: Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet 2004;364:1229-1235.
58. Øra I, van Tinteren H, Bergeron C, de Kraker J, on behalf of the SIOP Nephroblastoma Study Committee: Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study. Eur J Cancer 2007;43:131-136.
59. Pritchard J, Imeson J, Barnes J, Cotterill S, Gough D, Marsden HB, Morris-Jones P, Pearson D: Results of the United Kingdom Children's Cancer Study Group first Wilms' tumor study. J Clin Oncol 1995;13:124-133.
60. Grundy RG, Hutton C, Middleton H, Imeson J, Pritchard J, Kelsey A, Marsden HB, Vujanic GM, Taylor RE, for the UKCCSG: Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT Protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study. Pediatr Blood Cancer 2004;42:311-319.
61. Mitchell C, Pritchard Jones K, Shannon R, Hutton C, Stevens S, Machin D, Imeson J, Kelsey A, Vujanic GM, Gornall P, Walker J, Taylor R, Sartori P, Hale J, Levitt G, Messahael B, Middleton H, Grundy R, Pritchard J, for the United Kingdom Cancer Study Group: Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumor: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group. Eur J Cancer 2006;42:2554-2562.
62. Kutluk T, Varan A, Büyükpamukçu N, Atahan L, Çaǧlar M, Akyüz C, Büyükpamukçu M: Improved survival of children with Wilms' tumor. J Pediatr Hematol Oncol 2006;28:423-426.
63. Yildiz I, Yüksel L, Özkan A, Apak H, Celkan T, Danismend N, Büyükünal C, Söylet Y, Sarimurat N, Dervisoglu S, Aksoy F, Atkovar G, Okkan S: Multidisciplinary approach to Wilms' tumor: 18 years of experience. Jpn J Clin Oncol 2000;30:17-20.
64. Akyüz C, Yalcin B, Yildiz I, Hazar V, Akici F, Tokuc G, Buyukpamukcu N, Caglar M, Atahan L, Buyukunal C, Dervisoglu S, Atkovar G, Melikoglu M, Karpuzoglu G, Akbiyik N, Sander S, Darendeliler E, Kuyumcu U, Özseke N, Yörük A, Ayan I, Yaris N, Oguz A, Dagdeviren A, Sarialioglu F, Duzovali Ö, Tanyel A, Buyukpamukcu M: Treatment of Wilms' tumor: a report from the Turkish Pediatric Oncology Group. Pediatr Blood Cancer 2004;43:422.
65. Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritrchey ML, Shamberger RC, Thomas PRM, D'Angio GJ, Green DM: Radiation therapy for favorable histology Wilms' tumor: prevention of flank recurrence did not improve survival on National Wilms' Tumor Studies 3 and 4. Int J Radiat Oncol Biol Phys 2006;65:203-209.
66. Flentje M, Weirich A, Graf N, Pötter R, Zimmerman H, Ludwig R: Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival. Int J Radiat Oncol Biol Phys 1998;40:163-169.
67. Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finklestein JZ, Grundy P, Thomas PRM, Kim T, Shochat S, Haase G, Ritchey M, Kelalis P, D'Angio GJ: Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1994;12:2126-2131.
68. Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM: Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol 2006;24:2352-2358.
69. Shearer P, Parham DM, Fontanesi J, Kumar M, Lobe TE, Fairclough D, Douglass EC, Wilimas J: Bilateral Wilms' tumor. Review of outcome, associated abnormalities, and late effects in 36 patients treated at a single institution. Cancer 1993;72:1422-1426.
70. Shamberger RC, Haase GM, Argani P, Perlman EJ, Cotton CA, Takashima J, Green DM, Ritchey ML: Bilateral Wilms' tumors with progressive or non-responsive disease. J Pediatr Surg 2006;41:652-657.
71. Szavay P, Luithle T, Garf N, Furtwangler R, Fuchs J: Primary hepatic metastases in nephroblastoma - a report of the SIOP/GPOH study. J Pediatr Surg 2006;41:168-172.